Milestone Scientific’s Q4 Preview Sees $2.31M Revenue, -$0.02 EPS Estimate
Milestone Scientific will report Q4 2025 revenue of $2.31 million and a -$0.02 per share loss on April 1. Full-year 2025 revenue is projected at $9.22 million with -$0.07 EPS, while 2026 forecasts hold at $10 million and -$0.06 EPS; analysts’ $1.00 price target suggests 229% upside and Outperform consensus.
1. Q4 2025 Earnings Preview
Milestone Scientific is scheduled to release Q4 2025 results on April 1. Consensus forecasts call for $2.31 million in revenue and a -$0.02 per share loss, setting a baseline for market reaction upon release.
2. Estimate Trends
Analyst projections for full-year 2025 remain at $9.22 million in revenue with -$0.07 EPS, unchanged over the past 90 days. The 2026 outlook also holds steady at $10 million in revenue and -$0.06 EPS, indicating flat growth expectations.
3. Q3 2025 Reported Results
In Q3 2025, Milestone Scientific generated $2.36 million in revenue, exceeding estimates by 4.75%, and posted a -$0.01 EPS, a 33.33% beat. The stock jumped 6.03% the day after results were released.
4. Price Targets and Ratings
Two analysts set an average one-year price target of $1.00, implying about 229% upside from the current level. GuruFocus values Milestone at $0.78 for a 157% upside, and brokerages maintain an average Outperform rating (2.0).